therapy

envie a um amigo share this

KRAS as a Modulator of the Inflammatory Tumor Microenvironment

Authors and Affiliations:

Flávia Pereira 1,2,3,4, Anabela Ferreira 1,2, Celso Albuquerque Reis 3,5,6, Maria João Sousa 1,2, Maria José Oliveira 3,4,5 and Ana Preto 1,2

1 Centre of Molecular and Environmental Biology (CBMA), Department of Biology, Campus de Gualtar, University of Minho, 4710-057 Braga, Portugal

KRAS as a Modulator of the Inflammatory Tumor Microenvironment

As mutações do gene KRAS são mutações oncogénicas frequentes em cancro, com maior prevalência em cancro pancreático, colorretal e de pulmão. Vários estudos têm sido desenvolvidos de forma a explorar o efeito das mutações KRAS, não somente no tumor, mas também no microambiente tumoral. A relevância do estudo do microambiente tumoral tem vindo a crescer devido ao seu já reportado impacto na modulação da atividade de células tumorais, ditando o sucesso da progressão tumoral.

12th International Symposium on Advanced Ovarian Cancer. Optimal Therapy. Update

Palau de la Música, Valencia, Spain

 

22 February, 2019

 

See more informations here: https://www.doctaforum.org/2019/aocsymp2019/

12th International Symposium on Advanced Ovarian Cancer. Optimal Therapy. Update

Palau de la Música, Valencia, Spain

 

22 February, 2019

 

See more informations here: https://www.doctaforum.org/2019/aocsymp2019/

14th Charles Rodolphe Brupbacher Symposium – Breakthroughs in Cancer Research and Therapy

ETH – Swiss Federal Institute of Technology, Zurich, Switzerland

 

30 January - 01 February, 2019 

 

See more informations here: http://crbrupba.myhostpoint.ch/en/symposium-2019/

14th Charles Rodolphe Brupbacher Symposium – Breakthroughs in Cancer Research and Therapy

ETH – Swiss Federal Institute of Technology, Zurich, Switzerland

 

30 January - 01 February, 2019 

 

See more informations here: http://crbrupba.myhostpoint.ch/en/symposium-2019/

Tracking Cancer: Detection and Monitoring, from Diagnosis to Therapy

CosmoCaixa Science Museum, Barcelona, Spain

 

04-06 February, 2018

 

See more informations here: https://www.eacr.org/conference/trackingcancers2019

Tracking Cancer: Detection and Monitoring, from Diagnosis to Therapy

CosmoCaixa Science Museum, Barcelona, Spain

 

04-06 February, 2018

 

See more informations here: https://www.eacr.org/conference/trackingcancers2019

Integrated computational modeling of bone metastasis, microenvironment and therapy

In the context of the multidisciplinary research project CancerSys - Multiscale modeling for personalized therapy of bone metastasis, financed by FCT and involving the institutions IDMEC, INESC-ID, IT (Instituto Superior Técnico, Universidade de Lisboa), Hospital de Santa Maria and IMM, a dynamic computational model capable of representing the biochemical aspects of bone metastases growth and the effect of the therapies used in this disease.

Supramolecular nanoscale assemblies for cancer diagnosis and therapy

Authors and Affiliations:

Sílvia Castro Coelho1, Maria Carmo Pereira1, Asta Juzeniene2, Petras Juzenas2, Manuel Álvaro Coelho1

 1 LEPABE, Department of Chemical Engineering, Faculty of Engineering, University of Porto, Rua Roberto Frias, PT-4200-465 Porto, Portugal

2 Department of Radiation Biology, Institute for Cancer Research, Radiumhospital, Oslo University Hospital, NO-0310 Oslo, Norway

 

Abstract: